Echocardiographic Evidence for Valvular Toxicity of Benfluorex: A Double-Blind Randomised Trial in Patients with Type 2 Diabetes Mellitus

• Geneviève Derumeaux,

  Affiliation Echocardiography Laboratory, Hôpital Louis Pradel, Lyon, France

  ⨯
• Laura Ernande,

  Affiliation Echocardiography Laboratory, Hôpital Louis Pradel, Lyon, France

  ⨯
• André Serusclat,

  Affiliation Department of Medical Imaging and Endocrinology, Hôpital Louis Pradel, Lyon, France

  ⨯
• Evelyne Servan,

  Affiliation Echocardiography Laboratory, Hôpital Louis Pradel, Lyon, France

  ⨯
• Eric Bruckert,

  Affiliation Department of Endocrinology and Metabolism, Hôpital Pitié Salpêtrière, Bâtiment Husson Mourier, Paris, France

  ⨯
• Hugues Rousset,

  Affiliation Internal Medicine, Centre Hospitalier, Pierre Benite, France

  ⨯
• Stephen Senn,

  Affiliation Department of Statistics, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Luc Van Gaal,

  Affiliation Department of Diabetology, Metabolism & Clinical Nutrition, Faculty of Medicine, University Hospital Antwerp, Edegem-Antwerp, Belgium

  ⨯
• Brigitte Picandet,

  Affiliation Institut de Recherches Internationales Servier, Courbevoie, France

  ⨯
• François Gavini,

  Affiliation Institut de Recherches Internationales Servier, Courbevoie, France

  ⨯
• Philippe Moulin ,

  * E-mail: philippe.moulin@chu-lyon.fr

  Affiliation Endocrinology Department, Hôpital Louis Pradel, Hospices Civils de Lyon, University Lyon1, Lyon, France

  ⨯
• on behalf the REGULATE trial investigators

  ¶Members of the REGULATE trial investigators can be found in the Acknowledgments.

  ⨯